THE KPM GROUP DC LLC

Lobbying for REZOLUTE · clinical stage biopharmaceutical company creating therapies for metabolic diseases

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income · posted Jan 14, 2026

Bills named in this filing 1

Lobbying activity 1

Pharmacy

S.4426, Promising Pathway Act 2.0 (118th Congress)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.